Diffusion Pharmaceuticals Inc Stock News

Report from HSBC and The Sustainability Consortium urges businesses to prepare supply chains for climate change and helps them understand risks

Raymond James upgraded shares of Tristate Capital (NASDAQ:TSC) from an outperform rating to a strong-buy rating in a report published on Wednesday, The Fly reports. They currently have $20.00 target p

Citigroup Inc. lowered its stake in Tristate Capital Holdings Inc (NASDAQ:TSC) by 66.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 11,548 shares of the fi

As it looks to reopen its theaters after the coronavirus lockdown, European cinema giant Vue International has restructured its leadership across the U.K. and Italy. Toby Bradon, general manager of Vu

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Zomedica Pharmaceuticals (ZOM – Research

18 at 7 PM EST to provide an open forum for discussing the growing demands on the American family when a family member has a chronic medical problem. Healthcare

NAIROBI, Kenya Jun 16 – Kenya National Union of Teachers (KNUT) has asked the Teachers Service Commission (TSC) to review the staffing norms in order to address the changing dynamics in the educatio

News articles about Diffusion Pharmaceuticals (NASDAQ:DFFN) have trended very negative on Tuesday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monit

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on KalVista Pharmaceuticals

The government must extend its coronavirus income support measures to cover a million people who have “fallen through the gaps” in the schemes, MPs said.

Se han comprado coches que no se tenían que comprar y se han comprado hospitales de campaña hinchables que a estas alturas ya no se van a usar. Esto es un desbarajuste total

For the last decade, Mike Robinson has been a pioneer in providing Compassion Cannabis care to individuals who either cannot find or cannot afford care for

US FDA approves first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children